EUVIMEDObjevte EUVIMED
Crossref

A Biomimetic Photocatalytic Nanomachine With Core‐Shell Architecture for Synergistic CO Gas Therapy and STING Activation in Triple‐Negative Breast Cancer

Na Qu, Jiale Xie, Zhenfei Wang, Jinlong Zhang, Chaofan Zhang, Hui Wang, Silu Li, Yu Chen, Jiulong Li, Yubing Guo, Xiaoyuan Ji, Yujing Li

Advanced Healthcare Materials · 2026-11-19

DOI: 10.1002/adhm.72001 ↗

At a glance

Journal article in Advanced Healthcare Materials, published online on 2026-11-19. Written by Na Qu and 11 co-authors. 41 references. Funded by: Natural Science Foundation of Beijing Municipality, Beijing Institute of Technology Research Fund Program for Young Scholars.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Carbon monoxide (CO) is a promising therapeutic agent for aggressive triple‐negative breast cancer (TNBC) with limited effective treatments. Moreover, its precise and safe delivery to tumors remains a challenge. However, conventional CO‐releasing strategies present inefficient substrate supply and poor spatiotemporal control. Here, we report a bioinspired photocatalytic nanomachine (g‐C 3 N 4 ‐Au@Hb@MnCO 3 nanoparticles, CAHM NPs) with a “catalytic core–capture layer mineralization shell” architecture that integrates CO 2 generation, capture, and photocatalytic conversion with Mn 2+ ‐mediated immunomodulation for synergistic antitumor therapy. The system is constructed by immobilizing hemoglobin (Hb) on Au‐deposited graphitic carbon nitride (g‐C 3 N 4 ‐Au), followed by in situ mineralization of a pH‐responsive manganese carbonate (MnCO 3 ) shell. In the acidic tumor microenvironment, MnCO 3 decomposes to release CO 2 and Mn 2+ . The captured CO 2 is efficiently photoreduced to CO under 650 nm laser irradiation, inducing immunogenic cell death, while the released Mn 2+ activates the STING pathway to promote dendritic cell maturation and enhance antitumor immunity. In vitro and in vivo studies demonstrate that CAHM NPs in the Laser group effectively suppress tumor growth and elicit robust immune responses, with minimal toxicity. This work presents a novel strategy for spatially controlled CO therapy combined with STING activation, offering a promising platform for the treatment of TNBC.

Funding

  • Natural Science Foundation of Beijing Municipality
  • Beijing Institute of Technology Research Fund Program for Young Scholars

Cite

APA

Qu, N., Xie, J., Wang, Z., Zhang, J., Zhang, C., Wang, H., Li, S., Chen, Y., Li, J., Guo, Y., Ji, X., & Li, Y. (2026). A Biomimetic Photocatalytic Nanomachine With Core‐Shell Architecture for Synergistic CO Gas Therapy and STING Activation in Triple‐Negative Breast Cancer. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.72001

Vancouver

Qu N, Xie J, Wang Z, Zhang J, Zhang C, Wang H, et al. A Biomimetic Photocatalytic Nanomachine With Core‐Shell Architecture for Synergistic CO Gas Therapy and STING Activation in Triple‐Negative Breast Cancer. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.72001

BibTeX
@article{Qu2026,
  author = {Qu, Na and Xie, Jiale and Wang, Zhenfei and Zhang, Jinlong and Zhang, Chaofan and Wang, Hui and Li, Silu and Chen, Yu and Li, Jiulong and Guo, Yubing and Ji, Xiaoyuan and Li, Yujing},
  title = {A Biomimetic Photocatalytic Nanomachine With Core‐Shell Architecture for Synergistic CO Gas Therapy and STING Activation in Triple‐Negative Breast Cancer},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.72001}
}
Start for free →